Events

RNA Leaders USA Congress 2024

September 4, 2024

Presentation: Pioneering an AI Foundation Model for the Discovery of Disease Mechanisms and RNA Therapeutics 

Panel: The Future of RNA Therapeutics 

Location: Boston

Date: September 4-5, 2024

Presenter: Brendan Frey, Founder, CIO, Deep Genomics  

40th Annual J.P. Morgan Healthcare Conference

January 12, 2022

Presentation: Deep Genomics Company Presentation

Location: San Francisco

Date: January 12, 2022

Presenter: Brendan Frey, Founder, CEO, Deep Genomics  

Oligonucleotide Therapeutics East Coast

December 9, 2021

Presentation: "Best practice for the oligonucleotide hit-to-lead process" -- Panel Moderator 

Location: Virtual

Date: December 9, 2021

Presenter: Jeffery Brown, Vice President and Head of Preclinical Research

Goldman Sachs Byte-ology 2021

December 9, 2021

Presentation: “The Convergence of Biotechnology and Technology: A Biotechs Panel” - Privates Panel 

Location: Virtual

Date: December 9, 2021

Presenter: Brendan Frey, Founder, CEO, Deep Genomics  

Foresight Institute Vision Weekend 2021

December 4, 2021

Presentation: “The Biotech Tree: Which biotech opportunities should we seize? Which risks must we avoid?" -- Panel 

Location: San Francisco

Date: December 4, 2021

Presenter: Amit Deshwar, Vice President and Head of Predictive Systems 

Vector Institute - Careers in AI: Health

November 10, 2021

Presentation: "AI Breakthroughs at Deep Genomics" - Keynote Speaker  

Location: Toronto/Virtual

Date: November 10, 2021

Presenter: Brendan Frey, Founder and CEO, Deep Genomics 

World Muscle Society Annual Congress 2021, Opening Session

September 22, 2021

Presentation: "Why AI will be the Foundation of 21st Century Medicine" - Keynote Speaker 

Location: Virtual

Date: September 22, 2021

Presenter:  Brendan Frey, Founder and CEO, Deep Genomics 

William Blair Biotech Focus Conference 2021

July 15, 2021

Presentation: “Putting the Tech in Biotech: AI and Future Disruptors” Panel

Location: Virtual

Date: July 15, 2021

Presenter: Brendan Frey, CEO, Deep Genomics